Procter Gamble (India) Today

PGHL Stock   5,169  21.90  0.43%   

Performance

0 of 100

 
Weak
 
Strong
Very Weak

Odds Of Distress

Less than 2

 
High
 
Low
Very Low
Procter Gamble is selling for under 5168.55 as of the 28th of November 2024; that is 0.43 percent increase since the beginning of the trading day. The stock's lowest day price was 5134.0. Procter Gamble has a very small chance of experiencing financial distress in the next few years, but has generated negative returns over the last 90 days. Equity ratings for Procter Gamble Health are calculated daily based on our scoring framework. The performance scores are derived for the period starting the 1st of June 2024 and ending today, the 28th of November 2024. Click here to learn more.
Business Domain
Pharmaceuticals, Biotechnology & Life Sciences
Category
Healthcare
Classification
Health Care
Procter Gamble is entity of India. It is traded as Stock on NSE exchange. The company has 16.6 M outstanding shares. More on Procter Gamble Health

Procter Stock Highlights

Most reasonable investors view market volatility as an opportunity to invest at a favorable price or to sell short against a bearish trend. Procter Gamble's investment highlights are automatically generated signals that are significant enough to either complement your investing judgment regarding Procter Gamble or challenge it. These highlights can help you better understand the position you are entering and avoid costly mistakes.
Thematic IdeaHealth Management (View all Themes)
Business ConcentrationPharmaceuticals, Pharmaceuticals, Biotechnology & Life Sciences, Health Care, Health Management, Health Care, Pharmaceuticals, Drug Manufacturers-Specialty & Generic, Healthcare (View all Sectors)
Procter Gamble's financial strength is of vital concern to both outside investors and internal stakeholders. Efficiency and cost control are keys to Procter Gamble's success, along with its ability to generate sufficient cash flow to pay bills, repay debt, and make a consistent year-to-year profit.
Debt Levels
Procter Gamble can leverage the use of borrowed funds to amplify returns from an investment. In general, analyzing the relationship between debt to total assets helps investors to understand Procter Gamble's financial leverage. It provides some insight into what part of Procter Gamble's total assets is financed by creditors.
Liquidity
Procter Gamble cash flow analysis is essential to understand how it generates and spends money over a specific period. It can also help you figure out where your money is going and how much cash you have available at a given moment. Procter Gamble Health has accumulated 95.6 M in total debt. Debt can assist Procter Gamble until it has trouble settling it off, either with new capital or with free cash flow. So, Procter Gamble's shareholders could walk away with nothing if the company can't fulfill its legal obligations to repay debt. However, a more frequent occurrence is when companies like Procter Gamble Health sell additional shares at bargain prices, diluting existing shareholders. Debt, in this case, can be an excellent and much better tool for Procter to invest in growth at high rates of return. When we think about Procter Gamble's use of debt, we should always consider it together with cash and equity.

Dividends Paid

4.36 Billion
Procter Gamble Health (PGHL) is traded on National Stock Exchange of India in India and employs 11 people. Procter Gamble is listed under Pharmaceuticals category by Fama And French industry classification. The company currently falls under 'Large-Cap' category with a current market capitalization of 87.37 B. Market capitalization usually refers to the total value of a company's stock within the entire market. To calculate Procter Gamble's market, we take the total number of its shares issued and multiply it by Procter Gamble's current market price. To manage market risk and economic uncertainty, many investors today build portfolios that are diversified across equities with different market capitalizations. However, as a general rule, conservative investors tend to hold large-cap stocks, and those looking for more risk prefer small-cap and mid-cap equities. Procter Gamble Health operates under Pharmaceuticals sector and is part of Health Care industry. The entity has 16.6 M outstanding shares. Procter Gamble Health has accumulated about 3.4 B in cash with 2.28 B of positive cash flow from operations.
Check Procter Gamble Probability Of Bankruptcy
Ownership Allocation
Procter Gamble owns a total of 16.6 Million outstanding shares. Procter Gamble has significant amount of outstanding shares owned by insiders. An insider is usually defined as a CEO, other corporate executive, director, or institutional investor who own at least 10% of the company's outstanding shares. Since such a large part of the company is owned by insiders, it is advisable to analyze if each of these insiders have been buying or selling the stock in recent months. Please note that no matter how many assets the company maintains, if the real value of the company is less than the current market value, you may not be able to make money on it.
Check Procter Ownership Details

Procter Gamble Health Risk Profiles

Although Procter Gamble's alpha and beta are two of the key measurements used to evaluate Procter Gamble's performance over the market, the standard measures of volatility play an important role as well.

Procter Stock Against Markets

Be your own money manager

Our tools can tell you how much better you can do entering a position in Procter Gamble without increasing your portfolio risk or giving up the expected return. As an individual investor, you need to find a reliable way to track all your investment portfolios. However, your requirements will often be based on how much of the process you decide to do yourself. In addition to allowing all investors analytical transparency into all their portfolios, our tools can evaluate risk-adjusted returns of your individual positions relative to your overall portfolio.

Did you try this?

Run Sectors Now

   

Sectors

List of equity sectors categorizing publicly traded companies based on their primary business activities
All  Next Launch Module

Procter Gamble Corporate Management

Elected by the shareholders, the Procter Gamble's board of directors comprises two types of representatives: Procter Gamble inside directors who are chosen from within the company, and outside directors, selected externally and held independent of Procter. The board's role is to monitor Procter Gamble's management team and ensure that shareholders' interests are well served. Procter Gamble's inside directors are responsible for reviewing and approving budgets prepared by upper management to implement core corporate initiatives and projects. On the other hand, Procter Gamble's outside directors are responsible for providing unbiased perspectives on the board's policies.
Zeal ShahCompliance SecProfile
Rekha BijoykumarManager CommunicationsProfile
Lars AtorfHead CommunicationsProfile
Renee ConnollyHead CommunicationsProfile

Additional Tools for Procter Stock Analysis

When running Procter Gamble's price analysis, check to measure Procter Gamble's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Procter Gamble is operating at the current time. Most of Procter Gamble's value examination focuses on studying past and present price action to predict the probability of Procter Gamble's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Procter Gamble's price. Additionally, you may evaluate how the addition of Procter Gamble to your portfolios can decrease your overall portfolio volatility.